Klompas Neil A
SEC insider (Form 3/4/5 filer). CIK 0001761857. Director at InMed Pharmaceuticals Inc. (INM). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 19, 2025. Located in VANCOUVER, A1.
Companies Klompas Neil A has filed insider reports for
- InMed Pharmaceuticals Inc. (INM): Director
Klompas Neil A
CIK: 0001761857
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INM
InMed Pharmaceuticals Inc.
Director